跳至主要内容
临床试验/NCT02434107
NCT02434107已完成不适用

Controlled and Prospective Randomised Study to Compare Complete Lymph Node Dissection Versus Watchful Waiting in Patients With Malignant Melanoma With a Tumour Thickness of 1,0mm+ and Evidence of Metastases in the Sentinel Node

University Hospital Tuebingen82 个研究点 分布在 1 个国家目标入组 483 人开始时间: 2005年12月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
483
试验地点
82
主要终点
Distant metastases free survival

研究概览

简要总结

Sentinel lymph node biopsy (SLNB) is considered as standard diagnostic procedure in melanoma patients carrying a reasonable risk for metastases. In numerous studies the prognostic role of micro metastases in the sentinel node (SN) was described. However, the prognostic value of a complete lymph node dissection in patients with a positive SN is still unclear.

This study was planned to analyse the survival outcome of patients with a positive SN receiving complete lymphadenectomy versus watchful waiting.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cutaneous melanoma with a tumour thickness of at least 1,00mm
  • Positive sentinel node with micro metastases of max. 2mm in diameter

排除标准

  • Mucosal or ocular melanoma
  • Cutaneous melanoma located in the head/neck region
  • Evidence of satellite, in transit or local metastases / recurrences
  • Macro metastases of the SN or micro metastases of >2mm in diameter
  • Additional immune-suppressive therapy
  • Pregnant of lactating women

结局指标

主要结局

Distant metastases free survival

时间窗: 3 Years

次要结局

  • Distant metastases free survival(5 Years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (82)

Loading locations...

相似试验